EUVIMEDOpdag EUVIMED
BeobachtungsstudieOpen access · CC BY-NC-ND 4.0

Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study

Judith Thomas, Abbish Kamalakkannan, Mirela Prgomet, Karina Gardner, Precious McGuire, Geoffrey Campbell, Andrew Georgiou

Australian Journal of Primary Health · 2025

DOI: 10.1071/py24170 ↗

At a glance

Beobachtungsstudie in Australian Journal of Primary Health, 2025. Written by Judith Thomas and 6 co-authors. Institution: Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia. Major MEDLINE topics: Antiviral Agents, COVID-19, COVID-19 Drug Treatment, Drug Prescriptions. Cited 1 times so far (Crossref); 26 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Digital Health CRC.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

This study aimed to gain a comprehensive understanding of oral COVID-19 antiviral prescribing in Australian general practice.

Methods

The study was a retrospective observational cohort study. Routinely collected, de-identified, Australian general practice consultation and prescription data was used with permission from participating primary health networks, from 938 general practices between March 2022 and September 2023. Study cohorts were patients aged ≥15 encompassing (i) an ‘antiviral cohort’ comprising patient records with ≥1 oral COVID-19 antiviral prescription/s and (ii) a ‘comparison cohort’ of remaining records. Primary outcome measures were the frequency and type of oral COVID-19 antivirals prescribed, and sociodemographic and health characteristics of patients prescribed antivirals. Secondary measures were the frequency of antiviral repeat prescribing and consultation modality.

Results

Within the study population of 3,813,051 patients, oral COVID-19 antivirals were prescribed to 3.39% (129,267) of patients including 14.79% (82,215/555,757) of patients aged ≥70 years. Molnupiravir prescribing exceeded nirmatrelvir–ritonavir across all study months. Proportionally, antiviral prescribing was higher in the female population (74,709/2,059,676: 3.63%), Victoria (81,184/2,222,837: 3.65%), residing in high socioeconomic advantage areas (87,530/2,224,501: 3.93%), and ages 80–84 years (16,419/100,911: 16.27%). Of patients prescribed COVID-19 antivirals, 7.27% (9402/129,267) had repeat prescribing. Cardiovascular and musculoskeletal conditions were the most prevalent chronic diagnoses, and telehealth (58,660/107,727: 54.45%) exceeded face-to-face consultations.

Conclusions

Oral COVID-19 antiviral prescribing volumes in general practice may serve as an indicator of periods of increased transmission of COVID-19, through increases in prescribing activity. Telehealth exceeding face-to-face for oral COVID-19 antiviral prescribing supports continued access to telehealth to reduce exposure to COVID-19 and provide time-critical access to treatment.

Subjects

MeSH terms (MEDLINE)

Antiviral AgentsCOVID-19COVID-19 Drug TreatmentDrug PrescriptionsGeneral PracticePractice Patterns, Physicians'AdolescentAdultAgedAged, 80 and overFemaleHumansMaleMiddle AgedYoung AdultAdministration, OralAustraliaRetrospective Studies

Substances

Antiviral Agents

Authors and institutions

  • Australian Institute of Health Innovation, Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, NSW 2109, Australia.
  • Outcome Health, Melbourne, Vic 3130, Australia.
  • Eastern Melbourne Primary Health Network, Melbourne, Vic 3128, Australia.
  • Langpark Medical Centre, Melbourne, Vic 3910, Australia.

Funding

  • Digital Health CRC

Cite

APA

Thomas, J., Kamalakkannan, A., Prgomet, M., Gardner, K., McGuire, P., Campbell, G., & Georgiou, A. (2025). Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study. Australian Journal of Primary Health. https://doi.org/10.1071/py24170

Vancouver

Thomas J, Kamalakkannan A, Prgomet M, Gardner K, McGuire P, Campbell G, et al. Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study. Australian Journal of Primary Health. 2025. doi:10.1071/py24170

BibTeX
@article{Thomas2025,
  author = {Thomas, Judith and Kamalakkannan, Abbish and Prgomet, Mirela and Gardner, Karina and McGuire, Precious and Campbell, Geoffrey and Georgiou, Andrew},
  title = {Oral COVID-19 antiviral prescribing in Australian general practice – a retrospective observational study},
  journal = {Australian Journal of Primary Health},
  year = {2025},
  doi = {10.1071/py24170}
}
Start for free →